Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

White matter volume is decreased in the brain of patients with neuromyelitis optica.
Social cognition in pediatric-onset multiple sclerosis (MS).
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Major stressful life events in adulthood and risk of multiple sclerosis.
Olfactory dysfunction in multiple sclerosis.
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
A genome-wide association study in progressive multiple sclerosis.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica.
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Plasma chemerin levels in patients with multiple sclerosis.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
[Gluten-related disorders and demyelinating diseases.]
No quiet surrender: molecular guardians in multiple sclerosis brain.

Pages